Research interests

Designing hepatitis C virus (HCV) E1E2 glycoproteins for structural studies and vaccine studies.

Producing and designing novel HIV-1 envelope glycoproteins.

specialisation

hepatitis C virus (HCV), HIV-1, envelope glycoproteins, vaccines, nanoparticles

Research output

  1. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

    Research output: Contribution to journal › Article › Academic › peer-review

  3. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    Research output: Contribution to journal › Article › Academic › peer-review

View all (38) »

ID: 85314